Smith & Nephew plc vs Spotify Technology — how do they compare? Smith & Nephew plc trades at $27.72 (market cap $11.63B), while Spotify Technology trades at $523.66 (market cap $108.68B). The key difference: Spotify Technology is far larger — about 9.3× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.85% dividend while Spotify Technology pays none. Which is the better fit depends on your goals.
| SNN | SPOT | |
|---|---|---|
Market Cap | $11.63B | $108.68B |
Sector | Health | Media |
52-Week High | $38.53 | $738.53 |
52-Week Low | $27.80 | $412.75 |
Enterprise Value | $14.66B | $98.31B |
Dividend Yield | 2.85% | — |
Signals from Pluang's Aura AI — not financial advice
Smith & Nephew (SNN) trades at $27.87, down 3.46% over 24 hours and near its 52-week low. The stock shows a bearish technical trend with mixed sentiment; recent earnings have mostly beaten expectations, but Q2 2026 revenue growth missed and guidance was cut. Fundamentals are solid with revenue rising to $6.16B in 2025 and net income margin improving to 10.08%, though debt levels have increased. The company faces competitive pressures in key markets like U.S. Orthopaedics.
Outlook is cautious: valuation ratios like P/E of 18.96 are reasonable, but analyst consensus is Hold (65%) due to execution risks and CFO departure. Opportunities include innovation in surgical robotics and new product launches, but investors should monitor U.S. market weakness and debt management for sustained recovery.
Spotify (SPOT) trades at $528.64, down 2.54% on the day, but maintains a bullish technical outlook with strong fundamental momentum. The company reported record profitability with net income reaching $2.21 billion in 2025, representing a 12.87% margin, while revenue grew to $17.19 billion. Recent news highlights a $1.5 billion share repurchase authorization and ongoing subscriber growth, though Q2 2026 earnings missed expectations.
The stock presents a compelling growth story with expanding margins and positive cash flow generation, but faces valuation risks with a P/E of 28.61. Analyst consensus remains bullish with a $590.29 price target, representing 11.7% upside potential. Key risks include execution pressure to justify premium valuation and competitive threats in the audio streaming space.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →